SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Eiko Lifesciences touches the roof as its arm enters into agreement with S J Logistics (India)

18 Dec 2024 Evaluate

Eiko Lifesciences is currently trading at its upper limit of Rs. 67.36, up by 6.12 points or 9.99% from its previous closing of Rs. 61.24 on the BSE.

The scrip opened at Rs. 61.99 and has touched a high and low of Rs. 67.36 and Rs. 61.99 respectively. So far 92223 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 81.32 on 25-Jan-2024 and a 52 week low of Rs. 45.10 on 04-Jun-2024.

Last one week high and low of the scrip stood at Rs. 67.36 and Rs. 59.21 respectively. The current market cap of the company is Rs. 93.36 crore.

The promoters holding in the company stood at 24.40%, while Non-Institutions held 75.60% stake in the company.

Eiko Lifesciences’ subsidiary-- EikoVivify Logistics has entered into Agreement dated December 18, 2024, with S J Logistics (India) for carrying out Business Operations relating to leasing, renting, and managing shipping containers for logistics, storage, and transportation of goods along with Maintenance and Management of Cargo Container under Container Service Management Agreement. Container Management Service Agreement will generate direct revenue stream of approximately Rs 65 crore over a period of 5 years.

Eiko Lifesciences is a leading manufacturer, supplier and exporter of Specialty Chemicals and Pharma Intermediates in India and Globally.


Eiko Lifesciences Share Price

51.38 1.10 (2.19%)
06-May-2026 09:35 View Price Chart
Peers
Company Name CMP
BASF India 3680.00
Tata Chemicals 821.05
SRF 2634.95
Pidilite Inds. 1384.00
Deepak Nitrite 1771.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×